In examining the capacity of ALDH1A3 knockdown to reverse tumor growth, we found that knockdown of ALDH1A3 attenuated the pro-oncogene effects of ARL4C overexpressed in GBM cells (Fig. 4C and 4D). This evidence concerns the gene ARL4C and glioblastoma.